Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 15,288 | 1,020 | 3,138 | 3,053 | 3,805 |
| Gross Profit | 15,288 | 1,020 | 3,138 | 3,053 | 3,805 |
| Operating Expenses | 13,048 | 13,056 | 13,679 | 14,894 | 12,809 |
| Operating Income | 2,240 | -12,036 | -10,541 | -11,841 | -9,004 |
| Other Income | 57 | 113 | 25 | 150 | 398 |
| Pre-tax Income | 2,297 | -11,923 | -10,516 | -11,691 | -8,606 |
| Net Income Continuous | 2,297 | -11,923 | -10,516 | -11,691 | -8,606 |
| Net Income | $2,297 | $-11,923 | $-10,516 | $-11,691 | $-8,606 |
| EPS Basic Total Ops | 4.98 | -6.24 | -1.36 | -1.56 | -0.32 |
| EPS Basic Continuous Ops | 4.98 | -6.22 | -1.38 | -1.55 | -0.31 |
| EPS Diluted Total Ops | 4.98 | -6.24 | -1.36 | -1.56 | -0.32 |
| EPS Diluted Continuous Ops | 4.98 | -6.22 | -1.38 | -1.55 | -0.31 |
| EBITDA(a) | $2,556 | $-11,718 | $-10,216 | $-11,560 | $-8,739 |